The sprawling 200-acre Active Pharmaceutical Ingredient (API) Industrial Park in Gazaria, Munshiganj, achieved commercial operational status today, with 28 pharmaceutical synthesis plants firing their reaction kilns.
Historically, domestic drug makers relied on foreign suppliers for over 85% of their basic pharmaceutical chemicals. With local synthesis underway, Bangladesh expects to save $1.4 billion annually in import foreign exchange while insulating patients against global supply interruptions.
“Domestic production of raw chemical molecules for antibiotics and oncology drugs slashes import reliance, positioning Bangladesh as an affordable medicine exporter to 150 nations.”
The facility includes a centralized effluent treatment plant with advanced reverse-osmosis filtration to ensure strict ecological safety for nearby water bodies.